Prognostic significance of survivin in breast cancer: meta-analysis.

作者: Yanyan Li , Xuelei Ma , Xi Wu , Xiaoxiao Liu , Lei Liu

DOI: 10.1111/TBJ.12303

关键词:

摘要: Survivin, an inhibitor of apoptosis protein, is a potentially prognostic factor and therapeutic target in breast carcinoma, but no consensus exists based on heterogeneous data. The aim of …

参考文章(43)
Bruce D. Cheson, Nancy L. Bartlett, Julie M. Vose, Andres Lopez-Hernandez, Amanda L. Seiz, Anne T. Keating, Setareh Shamsili, A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B-cell lymphoma. Cancer. ,vol. 118, pp. 3128- 3134 ,(2012) , 10.1002/CNCR.26510
Alessandra Giodini, Dario C. Altieri, Paola Fortugno, Simona Tognin, Pier Carlo Marchisio, Janet Plescia, Daniel S. O'Connor, Karen M. Padgett, Nathan R. Wall, Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function. Journal of Cell Science. ,vol. 115, pp. 575- 585 ,(2002) , 10.1242/JCS.115.3.575
Mariano Monzó, Rafael Rosell, Enriqueta Felip, Julio Astudillo, José Javier Sánchez, José Maestre, Cristina Martín, Albert Font, Agustí Barnadas, Albert Abad, A Novel Anti-Apoptosis Gene: Re-expression of Survivin Messenger RNA as a Prognosis Marker in Non–Small-Cell Lung Cancers Journal of Clinical Oncology. ,vol. 17, pp. 2100- 2100 ,(1999) , 10.1200/JCO.1999.17.7.2100
XIAOCHI CHEN, TIEZHENG WANG, DEYONG YANG, JIANBO WANG, XIANCHENG LI, ZHONGZHOU HE, FENG CHEN, XIANGYU CHE, XISHUANG SONG, Expression of the IAP protein family acts cooperatively to predict prognosis in human bladder cancer patients Oncology Letters. ,vol. 5, pp. 1278- 1284 ,(2013) , 10.3892/OL.2013.1150
Gamze Gokoz Dogu, Metin Ozkan, Figen Ozturk, Mustafa Dikilitas, Ozlem Er, Ahmet Ozturk, Triple-negative breast cancer: immunohistochemical correlation with basaloid markers and prognostic value of survivin Medical Oncology. ,vol. 27, pp. 34- 39 ,(2010) , 10.1007/S12032-009-9166-3
Lilach Kleinberg, Vivi Ann Flørenes, Jahn M. Nesland, Ben Davidson, Survivin, a member of the inhibitors of apoptosis family, is down-regulated in breast carcinoma effusions. American Journal of Clinical Pathology. ,vol. 128, pp. 389- 397 ,(2007) , 10.1309/E899BG1282M5D505
Evgeny Yakirevich, Ayman Samkari, Michael P. Holloway, Shaolei Lu, Kamaljeet Singh, Jovian Yu, Mary Anne Fenton, Rachel A. Altura, Total Survivin and acetylated Survivin correlate with distinct molecular subtypes of breast cancer Human Pathology. ,vol. 43, pp. 865- 873 ,(2012) , 10.1016/J.HUMPATH.2011.07.014
L. Kostadima, G. Pentheroudakis, G. Fountzilas, M. Dimopoulos, D. Pectasides, H. Gogas, C. Christodoulou, E. Samantas, D. Bafaloukos, P. Arapantoni, H. Kalofonos, P. Papakostas, T. Economopoulos, A. Bamias, N. Pavlidis, U. Stropp, R. Wirtz, G. Hennig, Survivin and glycodelin transcriptional activity in node-positive early breast cancer: mRNA expression of two key regulators of cell survival Breast Cancer Research and Treatment. ,vol. 100, pp. 161- 167 ,(2006) , 10.1007/S10549-006-9240-X
Yoshitaka Yamada, Toshihiko Kuroiwa, Toshimasa Nakagawa, Yoshinaga Kajimoto, Takehiko Dohi, Haruhito Azuma, Motomu Tsuji, Kazuhiro Kami, Shin-Ichi Miyatake, Transcriptional expression of survivin and its splice variants in brain tumors in humans. Journal of Neurosurgery. ,vol. 99, pp. 738- 745 ,(2003) , 10.3171/JNS.2003.99.4.0738